tykhr
sign in
free sign up
Alvotech
Drug Manufacturers - Specialty & Generic
Healthcare
ALVO
301 M shares
NASDAQ US
traded
09 Apr 2025
listed
no
open
8.00
52 week high
14.46
high
8.88
52 week low
8.06
low
7.35
growth
-37.03 %
previous Close
8.06
P/E ratio
market cap
3.60 B
div yield
0
usd
Sep 2024
qoq
revenue
103 M
-48.23 %
net incoming
-11.39 M
-117.47 %
eps
0.00 %
-110.71 %
eps surprise
52.38 %
net profit margin
-11.07 %
-43.00 %
operating incoming
12.73 M
-86.15 %
net change in cash
107 M
299.25 %
cash on hand
118 M
980.72 %
cost of revenue
39.81 M
-11.94 %
top